SOCIETY OF TOXICOLOGY (SOT) 58TH ANNUAL MEETING AND TOXEXPO

Noushin Dianat, 6 March 2019 | Past event

Cyprio is proudly presenting at the Society of Toxicology (SOT) 2019 annual meeting where attendees can learn more about the company’s proprietary BioPearl technology, products and achievements thus far.

It will be our pleasure to host you at our booth, number 4177. Cyprio’s innovative HepatoPearl & RGPearl models for high throughput drug screening and toxicity purposes will be the main highlights of the presentations.

Dr. Noushin Dianat, the CEO of Cyprio, and Dr. Jérôme Caron, Cyprio’s R&D project manager, will be present at this event.

Additionally, two posters will be presented around our novel liver models and their applications. Don’t hesitate to come and join us in front of the posters and at the booth to discuss:

• Poster board number P310: CryoHepatoPearl: Ready-to-Use Cryopreserved 3D Human Liver Model
  Presentation Date: 03/11/2019 – 1:30 PM to 3:00 PM

• Poster board number P221: RGPearl: Innovative 3D HepaRG Microtissue Model for Safety Assessment
  Presentation Date: 03/13/2019 – 1:30 PM to 3:00 PM

Looking forward to seeing you in Baltimore!

Aucun Commentaire »

Ecopa 2018 Symposium

Noushin Dianat, 21 October 2018 | Past event

This year’s European Consensus-Platform for Alternatives (ECOPA) Symposium will be held from 5th to 6th November in Paris.

The French platform for the development of alternative methods in animal testing (Francopa) has organized the 2018 symposium with exciting talks around:

“How new experimental tools in life sciences challenge the 3Rs vision?”

HepatoPearls: New generation of liver-mimicking spheroids
5th November 2018 – 1:50 pm – 2:10 pm

Looking forward to seeing you soon in Paris!

Aucun Commentaire »

ALTERTOX ACADEMY HANDS-ON TRAINING

Noushin Dianat, 30 March 2018 | Past event

Aucun Commentaire »

Society of Toxicology (SOT) 57th annual meeting and ToxExpo

 , 5 January 2018 | Past event

Cyprio will attend the SOT 2018 annual meeting where attendees can learn more about the company’s technology, products and achievements thus far.

Cyprio is looking forward to presenting their exciting, patented, HepatoPearl technology for high throughput drug screening. Please don’t hesitate to visit our booth, number 1420.

We will also present two posters about two different applications of our HepatoPearls at SOT:

• Poster board number P451: Novel Liver Spheroids for High-Throughput Drug-Drug Interaction Screening by Next-Generation-Sequencing
• Poster board number P785: HepatoPearl: A Novel Tool for In Vitro Predictive Hepatotoxicity Screening

Looking forward to seeing you there!

Aucun Commentaire »

Society for Laboratory Automation and Screening (SLAS) International conference

 , 4 January 2018 | Past event

This year SLAS international conference will be held in San Diego, California and Cyprio has signed on to give a talk about their patented HepatoPearl technology entitled “Automation and high throughput technologies”. Cyprio’s session will be on February 5th, 2018 at 12-12:30pm. As always, guests are all invited to come and learn more about the HepatoPearl model and the company itself.

www.slas2018.org

Aucun Commentaire »

3D Cell Model Congress

 , 3 January 2018 | Past event

Cyprio will present new applications of their HepatoPearl drug screening technology on January 25, 2018 at 16:30 in Berlin. You are all invited to learn more about Cyprio’s exciting new developments.

3dcellmodelscongress.com/events/3d-cell-models-congress

Aucun Commentaire »

Cyprio Webinar

 , 2 January 2018 | Past event

Cyprio Webinar: HepatoPearls, a new liver-mimicking 3D cellular model for drug screening

Speaker: Dr Noushin Dianat, CEO of Cyprio

We are pleased to announce that Cyprio will host its very first webinar to present BioPearl technology and the innovative Liver 3D cellular model, HepatoPearl.

Do you want to know more about HepatoPearls and their application in drug screening? Cyprio will hold a webinar on Friday 2nd February 2018 at 3pm Paris local time (UTC +1). With a WebEx account, you are free to subscribe to the event link below. If you don’t have a WebEx account, you just need to subscribe to our Newsletter on “contact” page and the link to the webinar will be communicated to you automatically.

https://meetings.webex.com/collabs/meetings/view?uuid=M4TC3UUUY9VI0DVZ9NGXBJ5OIU-1AYW5&ucs=email

Aucun Commentaire »

World Preclinical Congress Europe

 , 21 December 2017 | Past event

www.worldpreclinicaleurope.com/3D-Cellular-Models/

Cyprio’s HepatoPearls made another appearance in the “3D cellular models; taking screening into a new dimension” session. While the HepatoPearls were being presented to the audience, Cyprio also presented the results of a collaborative project with Sanofi for high throughput drug-drug interaction screenings.

Our very own CEO, Noushin Dianat, was interviewed during the conference:
www.worldpreclinicaleurope.com/interviews/

Aucun Commentaire »

ALTERTOX academy hands-on training

 , 20 December 2017 | Past event

ALTERTOX academy (ex-CAAT academy) hands-on training: Updates on the Hepatotoxicity AOP Landscape and on the ADME Field Edition 2

www.caat-academy.org

Cyprio’s model, HepatoPearl, was introduced and presented to attendees. Participants of the workshop were given the opportunity to work with this innovative liver 3D cellular model while the Cyprio team explained interesting features about this novel product. This was also the very first time researchers were given the opportunity to work with the HepatoPearls.

Aucun Commentaire »

World Preclinical Congress (WPC)

 , 16 December 2017 | Past event

Cyprio’s CEO, Noushin Dianat, presented how our innovative technology has redefined the limits of 3D Cell Culture in the “3D cellular models” session at World Preclinical Congress.

www.worldpreclinicalcongress.com/wpc/17

Aucun Commentaire »